The p110α isoform of phosphatidylinositol 3-kinase is essential for polyomavirus middle T antigen-mediated transformation

Journal of Virology

Volumn 81, Issue 13, 2007, Pages 7069-7076

  Utermark, Tamara ^a   Schaffhausen, Brian S ^b   Roberts, Thomas M ^a   Zhao, Jean J ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GROWTH FACTOR RECEPTOR; ISOPROTEIN; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA; PROTEIN P110; PROTEIN P110ALPHA; PROTEIN SH2; UNCLASSIFIED DRUG; VIRUS MIDDLE T ANTIGEN; 1 PHOSPHATIDYLINOSITOL 3 KINASE P110 SUBUNIT, MOUSE; 1-PHOSPHATIDYLINOSITOL 3-KINASE P110 SUBUNIT, MOUSE; VIRUS T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; SRC HOMOLOGY DOMAIN; VIRUS CELL TRANSFORMATION; AMINO ACID SUBSTITUTION; ANIMAL; CELL LINE; CELL TRANSFORMATION; COMPARATIVE STUDY; ENZYMOLOGY; GENETICS; METABOLISM; MISSENSE MUTATION; PATHOLOGY;

MURINAE; POLYOMAVIRUS; RODENTIA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; FIBROBLASTS; HUMANS; MICE; MUTATION, MISSENSE; POLYOMAVIRUS; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY;

EID: 34250848181     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00115-07     Document Type: Article

References (55)

1. Bolen, J. B., C. J. Thiele, M. A. Israel, W. Yonemoto, L. A. Lipsich, and J. S. Brugge. 1984. Enhancement of cellular src gene product associated tyrosyl kinase activity following polyomavirus infection and transformation. Cell 38:767-777.
2. Bronson, R., C. Dawe, J. Carroll, and T. Benjamin. 1997. Tumor induction by a transformation-defective polyomavirus mutant blocked in signaling through She. Proc. Natl. Acad. Sci. USA 94:7954-7958.
3. Campbell, K. S., E. Ogris, B. Burke, W. Su, K. R. Auger, B. J. Druker, B. S. Schaffhausen, T. M. Roberts, and D. C. Pallas. 1994. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proc. Natl. Acad. Sci. USA 91:6344-6348.
4. Carmichael, G., B. S. Schaffhausen, G. Mandel, T. J. Liang, and T. L. Benjamin. 1984. Transformation by polyomavirus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen. Proc. Natl. Acad. Sci. USA 81:679-683.
5. Cecena, G., F. Wen, R. D. Cardiff, and R. G. Oshima. 2006. Differential sensitivity of mouse epithelial tissues to the polyomavirus middle T oncogene. Am. J. Pathol. 168:310-320.
6. Chen, L., X. Wang, and M. M. Fluck. 2006. Independent contributions of polyomavirus middle T and small T to the regulation of early and late gene expression and DNA replication. J. Virol. 80:7295-7307.
7. Cheng, S. H., R. Harvey, P. C. Espino, K. Semba, T. Yamamoto, K. Toyoshima, and A. E. Smith. 1988. Peptide antibodies to the human c-fyn gene product demonstrate pp59c-fyn is capable of complex formation with the middle-T antigen of polyomavirus. EMBO J. 7:3845-3855.
8. Courtneidge, S. A., and A. Heber. 1987. An 81 kd protein complexed with middle T antigen and pp60c-src: a possible phosphatidylinositol kinase. Cell 50:1031-1037.
9. Courtneidge, S. A., and A. E. Smith. 1983. Polyomavirus transforming protein associates with the product of the c-src cellular gene. Nature 303:435-439.
10. Courtneidge, S. A., and A. E. Smith. 1984. The complex of polyomavirus middle-T antigen and pp60c-src. EMBO J. 3:585-591.
11. Dilworth, S. M. 2002. Polyomavirus middle T antigen and its role in identifying cancer-related molecules. Nat. Rev. Cancer 2:951-956.
12. Dilworth, S. M., C. E. Brewster, M. D. Jones, L. Lanfrancone, G. Pelicci, and P. G. Pelicci. 1994. Transformation by polyomavirus middle T-antigen involves the binding and tyrosine phosphorylation of She. Nature 367:87-90.
13. Druker, B. J., L. E. Ling, B. Cohen, T. M. Roberts, and B. S. Schaffhausen. 1990. A completely transformation-defective point mutant of polyomavirus middle T antigen which retains full associated phosphatidylinositol kinase activity. J. Virol. 64:4454-4461.
14. Engelman, J. A., J. Luo, and L. C. Cantley. 2006. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7:606-619.
15. Foukas, L. C., M. Claret, W. Pearce, K. Okkenhaug, S. Meek, E. Peskett, S. Sancho, A. J. Smith, D. J. Withers, and B. Vanhaesebroeck. 2006. Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 441:366-370.
16. Freund, R., R. T. Bronson, and T. L. Benjamin. 1992. Separation of immortalization from tumor induction with polyoma large T mutants that fail to bind the retinoblastoma gene product. Oncogene 7:1979-1987.
17. Freund, R., C. J. Dawe, J. P. Carroll, and T. L. Benjamin. 1992. Changes in frequency, morphology, and behavior of tumors induced in mice by a polyomavirus mutant with a specifically altered oncogene. Am. J. Pathol. 141: 1409-1425.
18. Glover, H. R., C. E. Brewster, and S. M. Dilworth. 1999. Association between sre-kinases and the polyomavirus oncogene middle T-antigen requires PP2A and a specific sequence motif. Oncogene 18:4364-4370.
19. c-src. J. Virol. 64:105-112.
20. Griffin, B. E., Y. Ito, U. Novak, N. Spurr, S. Dilworth, N. Smolar, R. Pollack, K. Smith, and D. B. Rifkin. 1980. Early mutants of polyomavirus(dl8 and dl23) with altered transformation properties: is polyomavirus middle T antigen a transforming gene product? Cold Spring Harbor Symp. Quant. Biol. 44:271-282.
21. Guy, C. T., R. D. Cardiff, and W. J. Muller. 1992. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12:954-961.
22. Hong, Y. K., A. Mikami, B. Schaffhausen, T. Jun, and T. M. Roberts. 2003. A new class of mutations reveals a novel function for the original phosphatidylinositol 3-kinase binding site. Proc. Natl. Acad. Sci. USA 100:9434-9439.
23. fyn with middle tumor antigen in murine polyomavirus-transformed rat cells. J. Virol. 63:2343-2347.
24. Hunter, T., M. A. Hutchinson, and W. Eckhart. 1984. Polyoma middle-sized T antigen can be phosphorylated on tyrosine at multiple sites in vitro. EMBO J. 3:73-79.
25. Hutchinson, J., J. Jin, R. D. Cardiff, J. R. Woodgett, and W. J. Muller. 2001. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol. Cell. Biol. 21:2203-2212.
26. Ichaso, N., and S. M. Dilworth. 2001. Cell transformation by the middle T-antigen of polyomavirus. Oncogene 20:7908-7916.
27. Kaplan, D. R., M. Whitman, B. Schaffhausen, D. C. Pallas, M. White, L. Cantley, and T. M. Roberts. 1987. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity. Cell 50:1021-1029.
28. Kaplan, D. R., M. Whitman, B. Schaffhausen, L. Raptis, R. L. Garcea, D. Pallas, T. M. Roberts, and L. Cantley. 1986. Phosphatidylinositol metabolism and polyoma-mediated transformation. Proc. Natl. Acad. Sci. USA 83:3624-3628.
29. Knight, Z. A., B. Gonzalez, M. E. Feldman, E. R. Zunder, D. D. Goldenberg, O. Williams, R. Loewith, D. Stokoe, A. Balla, B. Toth, T. Balla, W. A. Weiss, R. L. Williams, and K. M. Shokat. 2006. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 125:733-747.
30. Kornbluth, S., M. Sudol, and H. Hanafusa. 1987. Association of the polyomavirus middle-T antigen with c-yes protein. Nature (London) 325:171-173.
31. Kypta, R. M., A. Hemming, and S. A. Courtneidge. 1988. Identification and characterization of p59fyn (a src-like protein tyrosine kinase) in normal and polyomavirus transformed cells. EMBO J. 7:3837-3844.
32. Larose, A., N. Dyson, M. Sullivan, E. Harlow, and M. Bastin. 1991. Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization. J. Virol. 65:2308-2313.
33. Lontax, M., and M. Fried. 2001. Polyomavirus disrupts ARF signaling to p53. Oncogene 20:4951-4960.
34. Magnusson, G., M. G. Nilsson, S. M. Dilworth, and N. Smolar. 1981. Characterization of polyoma mutants with altered middle and large T-antigens. J. Virol. 39:673-683.
35. Markland, W., B. A. Oostra, R. Harvey, A. F. Markham, W. H. Colledge, and A. E. Smith. 1986. Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250. J. Virol. 59:384-391.
36. Nishimura, R., W. Li, A. Kashishian, A. Mondino, M. Zhou, J. Cooper, and J. Schlessinger. 1993. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor. Mol. Cell. Biol. 13:6889-6896.
37. Ong, S. H., S. Dilworth, I. Hauck-Schmalenberger, T. Pawson, and F. Kiefer. 2001. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation. EMBO J. 20:6327-6336.
38. Oostra, B. A., R. Harvey, B. K. Ely, A. F. Markham, and A. E. Smith. 1983. Transforming activity of polyomavirus middle-T antigen probed by site-directed mutagenesis. Nature 304:456-459.
39. Pallas, D. C., L. K. Shahrik, B. L. Martin, S. Jaspers, T. B. Miller, D. L. Brautigan, and T. M. Roberts. 1990. Polyoma small and middle T antigens and SV40 small T antigen form stable complexes with protein phosphatase 2A. Cell 60:167-176.
40. Samuels, Y., Z. Wang, A. Bardelli, N. Silliman, J. Ptak, S. Szabo, H. Yan, A. Gazdar, S. M. Powell, G. J. Riggins, J. K. Willson, S. Markowitz, K. W. Kinzler, B. Vogelstein, and V. E. Velculescu. 2004. High frequency of mutations of the PIK3CA gene in human cancers. Science 304:554.
41. Schaffhausen, B., and T. L. Benjamin. 1981. Comparison of phosphorylation of two polyomavirus middle T antigens in vivo and in vitro. J. Virol. 40:184- 196.
42. Schaffhausen, B. S., and T. L. Benjamin. 1979. Phosphorylation of polyoma T antigens. Cell 18:935-946.
43. Sherr, C. J., and R. A. DePinho. 2000. Cellular senescence: mitotic clock or culture shock? Cell 102:407-410.
44. Su, W., W. Liu, B. S. Schaffhausen, and T. M. Roberts. 1995. Association of polyomavirus middle tumor antigen with phospholipase C-gamma 1. J. Biol. Chem. 270:12331-12334.
45. Talmage, D. A., R. Freund, A. T. Young, J. Dahl, C. J. Dawe, and T. L. Benjamin. 1989. Phosphorylation of middle T by pp60c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis. Cell 59:55-65.
46. Tooze, J. E. 1980. DNA tumor viruses. The molecular biology of tumor viruses, vol. 1 and 2. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
47. Treisman, R., U. Novak, J. Favaloro, and R. Kamen. 1981. Transformation of rat cells by an altered polyomavirus genome expressing only the middle T protein. Nature (London) 292:595-600.
48. Urich, M., M. Y. el Shemerly, D. Besser, Y. Nagamine, and K. Ballmer-Hofer. 1995. Activation and nuclear translocation of mitogen-activated protein kinases by polyomavirus middle-T or serum depend on phosphatidylinositol 3-kinase. J. Biol. Chem. 270:29286-29292.
49. Walter, G., R. Ruediger, C. Slaughter, and M. Mumby. 1990. Association of protein phosphatase 2A with polyomavirus medium tumor antigen. Proc. Natl. Acad. Sci. USA 87:2521-2525.
50. Webster, M. A., J. N. Hutchinson, M. J. Rauh, S. K. Muthuswamy, M. Anton, C. G. Tortorice, R. D. Cardiff, F. L. Graham, J. A. Hassell, and W. J. Muller. 1998. Requirement for both She and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell. Biol. 18:2344-2359.
51. Whitman, M., D. R. Kaplan, B. Schaffhausen, L. Cantley, and T. M. Roberts. 1985. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature 315:239-242.
52. Yang, S. I., R. L. Lickteig, R. Estes, K. Rundell, G. Walter, and M. C. Mumby. 1991. Control of protein phosphatase 2A by simian virus 40 small-t antigen. Mol. Cell. Biol. 11:1988-1995.
53. Yi, X., J. Peterson, and R. Freund. 1997. Transformation and tumorigenic properties of a mutant polyomavirus containing a middle T antigen defective in Shc binding. J. Virol. 71:6279-6286.
54. Zhao, J. J., H. Cheng, S. Jia, L. Wang, O. V. Gjoerup, A. Mikami, and T. M. Roberts. 2006. The p110a isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation. Proc. Natl. Acad. Sci. USA.
55. Zhao, J. J., O. V. Gjoerup, R. R. Subramanian, Y. Cheng, W. Chen, T. M. Roberts, and W. C. Hahn. 2003. Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell 3:483-495.